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Some monoclonal antibodies (Mabs) that react with the extremity of the tobacco mosaic virus (TMV) particle containing
the 5* end of the RNA are able to block the disassembly of TMV by ribosomes while others are totally devoid of such
activity. No correlation could be established between the binding kinetics and affinity of the Mabs and their inhibitory
capacity. An epitope map of the Mab binding sites was constructed on the basis of kinetic two-site binding assays with the
viral monomeric protein (TMVP) performed using biosensor technology (BIAcore). Mabs possessing inhibitory activity were
found to bind to the part of the TMVP surface closest to the central axis in the polymerized particle. As this part of the
subunit is known to interact with the viral RNA, it seems that inhibitory Mabs act by sterically preventing the interaction
between virus and ribosomes. This study illustrates the advantages of the biosensor technology for locating conformational
epitopes in viral proteins. q 1995 Academic Press, Inc.
INTRODUCTION units. Metatopes are present in both dissociated and
polymerized forms of the viral protein. It has been possi-
It has been demonstrated that in an in vitro translation ble to locate some cryptotopes in the TMVP molecule
system, disassembly of tobacco mosaic virus (TMV) par- because the corresponding anticryptotope antibodies re-
ticles can be induced by ribosomes that reach the 5* acted with natural or synthetic fragments of the protein
leader sequence of RNA. These ribosomes initiate trans- (Benjamini, 1977; Trifilieff et al., 1991; Van Regenmortel,
lation and dislodge the coat protein subunits during their 1986, 1990). This type of epitope mapping was not suc-
translocation on the viral RNA (Wilson, 1984; Wilson and cessful in the case of neotopes and metatopes because
Shaw, 1985). This cotranslational disassembly was also none of the corresponding antibodies reacted with any
shown to take place in vivo upon inoculation of plants linear fragments of TMVP. Some information on the loca-
with TMV (Shaw et al., 1986). tion of a limited number of neotopes and metatopes on
In an earlier study monoclonal antibodies (Mabs) TMV particles was obtained by immunoelectron micros-
raised against TMV coat protein (TMVP) were tested for copy (Dore et al., 1988, 1990). All examined antimetatope
their ability to block the in vitro disassembly of virions Mabs were found to react with the virion extremity con-
and the translation of viral RNA (Saunal et al., 1993). The taining the 5* end of the RNA, whereas the antineotope
majority of the antibodies that were tested reacted with Mabs reacted along the entire length of the virus particle.
the extremity of the virion that contained the 5* end of In a recent study the location of neotopes and meta-
the RNA and about half of these antibodies were found topes in TMV was further investigated by means of a new
to inhibit the translation of the viral RNA. Since this inhibi- biosensor technology (BIAcore, Pharmacia AB, Uppsala)
tory activity may be related to the property possessed using all available Mabs to TMV and TMVP (Saunal and
by many viral antibodies to neutralize virus infectivity, it Van Regenmortel, 1995). Double antibody capture assays
seemed of interest to investigate why some TMV antibod- with viral subunits and binding stoichiometry calculations
ies inhibited RNA translation and others did not. with virus particles made it possible to demonstrate the
Antibodies raised against TMV or dissociated TMVP presence of neotope and metatope specificities on parts
have been classified according to their ability to react of the viral surface where they had not been found before.
with three different types of epitopes known as crypto- Some metatopes were found to be present on the entire
topes, neotopes, and metatopes (Van Regenmortel, 1966, surface of the virion, indicating that these epitopes were
1990). Cryptotopes are epitopes that are buried inside located on the external surface A of the subunit (see Fig.
the assembled virus particle and become accessible to 1). Some neotopes were identified at the extremity of the
antibodies only after dissociation of the virion. Neotopes viral rod, i.e., on the polymerized surface E* of the subunit.
are specific for the quaternary structure of the virion and In earlier studies, this surface had been found to harbor
are thus not present at the surface of monomeric sub- only metatopes (Dore et al., 1988). The biosensor analy-
sis thus made it possible to distinguish two types of
antimetatope Mab reacting with surfaces A and E of the1 To whom correspondence and reprint requests should be ad-
dressed. Fax: 33 88 61 06 80. subunit, respectively, as well as two types of antineotope
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al., 1982, 1985). The Mabs were purified from ascitic
fluid by affinity chromatography on Hi Trap Protein A
(Pharmacia 17-0402-01) and dialyzed against 0.1% (w/v)
NaN3 in 0.02 M phosphate buffer, pH 7.0.
Measurement of inhibition of in vitro disassembly of
TMV by Mabs
Inhibition tests were performed as previously de-
scribed (Saunal et al., 1993) with slight modifications.
After centrifuging TMV–Mab complexes it was difficult
to remove completely the supernatants from the 200 ml
TL centrifuge tubes (TL-100 Beckman ultracentrifuge).
Small residual volumes (1–5 ml) remained in the tubes
and diluted the medium of translation (15 ml), which led
to variable results. In the present study, quantities of
FIG. 1. Schematic model of TMV protein subunits in monomeric form TMV, Mabs, and medium of translation used in the inhibi-
and in the virus particle, with an indication of which protein surface is tion assays were doubled so that any small volume of
recognized by each of the 23 Mabs. This allocation was done on the
supernatants remaining in the tubes became negligiblebasis of BIAcore mapping results (Saunal and Van Regenmortel, 1995).
in comparison with the 30 ml of translation medium. Re-It should be noted that earlier mapping attempts by ELISA had led to
some erroneous conclusions. For instance, Mabs 42P, 67P, and 249P sults were found to be more reproducible. Experiments
had previously been considered to be antimetatope antibodies (Al Mou- were performed at molar ratios of 50, 100, and 200 Mabs
dallal et al., 1985; Saunal et al., 1993). per virus particle.
Biosensor measurementsMab reacting with surfaces A* and E* of the virion (Fig.
1). The advantages of biosensor technology for analyzing
The biosensor instrument BIAcore (Pharmacia Biosen-
viral epitopes have been described in a recent review
sor AB, Uppsala, Sweden) allows real-time biospecific
(Van Regenmortel et al., 1994).
interaction analysis. This system uses the optical phe-
Two-site BIAcore binding assays with TMVP (Saunal
nomenon of surface plasmon resonance which detects
and Van Regenmortel, 1995) showed that the binding of
changes in optical properties at the surface of a thin gold
a first antimetatope Mab on one face of the subunit (such
film on the sensor chip (Lo¨fas and Johnsson, 1990). The
as surface E) did not prevent the binding of a second
sensor chip carries a dextran matrix on which one of the
antimetatope Mab on another face. Furthermore some
two reactants is covalently linked, while the other one
pairs of Mabs specific for surface E were able to bind
is introduced in a flux passing over the surface. The
concurrently to the same monomeric subunit. However,
resonance angle depends on the refractive index in the
no case was observed where two Mabs specific for sur-
vicinity of the surface which changes as the concentra-
face A bound to the same TMVP molecule.
tion of molecules on the surface is modified. This concen-
In view of the more refined mapping of TMV epitopes
tration is expressed in resonance units (RU). A signal of
made possible by the biosensor technology, we decided
1000 RU corresponds approximately to a surface concen-
to investigate if there was any correlation between the
tration change of 1 ng/mm2.
location of metatopes on TMVP and the capacity of the
The BIAcore system, sensor chip CM5, surfactant P20,
corresponding antibodies to inhibit cotranslational disas-
and amine coupling kit containing N-hydroxysuccinimide
sembly. In addition, the binding affinity and kinetics of
(NHS), N-ethyl-N*-(3-diethylaminopropyl) carbodiimide
the different antibodies were measured with BIAcore in
(EDC), as well as ethanolamine-HCl were from Phar-
order to establish if there was any correlation between
macia Biosensor AB.
antibody affinity and inhibitory capacity. The results
Preparation of the sensor surfaces. Most antibodies
showed that the Mabs possessing the strongest inhibi-
were immobilized covalently on the dextran matrix. Many
tory capacity bound to the part of the surface E closest
binding assays can be performed on the same chip con-
to the central axis of polymerized TMVP. Since this por-
taining immobilized antibodies since the bound antigen
tion of the TMVP surface is known to interact with the
can be dissociated from the covalently linked Mab by
viral RNA, these results suggest that the Mabs inhibit
injection of a few microliters of HCl. Usually regenerated
disassembly by directly preventing ribosomes from dis-
Mab surfaces can be used at least 50 times. Some Mabs
lodging viral subunits from the RNA.
were found to lose binding activity after HCl regeneration
and these were immobilized by means of a first layer of
MATERIALS AND METHODS
rabbit anti-mouse Fc globulins (RAM) covalently linked
to the dextran matrix. In this case, the noncovalentlyPurified TMV (common strain) and Mabs raised to TMV
and TMVP were from laboratory stocks (Al Moudallal et trapped Mab was removed during each regeneration cy-
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cle and it had to be reinjected on the RAM surface in
each successive binding assay. Anti-TMV Mabs 5V, 16P,
17V, 29V, 47P, 151P, and 173P were covalently bound to
the matrix while Mabs 25P, 167P, 181P, and 188P were
bound via RAM.
Covalent immobilization of RAM or Mabs to the sensor
chip was performed via primary amino groups using
standard procedures described previously (Fa¨gerstam et
al., 1990; Lo¨fas and Johnsson, 1990). The immobilization
run was performed at a flow of 5 ml/min in HBS buffer,
pH 7.4 (10 mM HEPES, 0.15 M NaCl, 3.4 mM EDTA,
0.05% surfactant P20). The carboxylated matrix was first
activated with 35 ml of an EDC/NHS mixture. Thirty micro-
liters of RAM Fc diluted in 10 mM acetate buffer, pH 5,
at 100 mg/ml or 30 ml of Mabs diluted in 10 mM acetate
buffer, pH 4, at 150 mg/ml was injected. Unreacted
groups were blocked by the injection of 30 ml of ethanol-
amine–HCl, pH 8.5, followed by three 5-ml washes of 0.1
N HCl to remove noncovalently bound antibodies.
Two-site binding assays with TMVP. After direct or
indirect immobilization of capture Mab1 on the sensor
surface, 30 ml of TMVP at 0.26 mg/ml was injected and
trapped by this Mab. The amount of trapped TMVP was
usually higher when the capture Mab was immobilized
directly on the matrix (230 to 1360 RU) than when it was
immobilized via a first layer of RAM (75 to 210 RU).
FIG. 2. Sensorgrams corresponding to two-site binding assays. (A)
The unoccupied sites of RAM Fc were blocked with The RU level at position a corresponds to the amount of capture Mab1
20 ml of a nonspecific Mab (ascitic fluid diluted 1/5) and (47P) covalently immobilized on the dextran matrix. Phase a to b corre-
Mab2 (30 ml, 150 mg/ml) was then injected and allowed sponds to the binding of 949 RU of TMVP. Phase b to c corresponds
to the injection of Mab2 (151P). The positive response (1637 RU) indi-to interact with TMVP.
cates that Mab 151P does not overlap the epitope occupied by MabThe concentration of molecules (expressed in RU) on
47P. Phase c to d corresponds to the injection of 10 ml of HCl 100 mM
the sensor chip surface is monitored continuously over for the regeneration of the Mab1-immobilized surface by dissociation
time and is registered as a sensorgram. The y axis of of noncovalently bound molecules. (B) The RU level at position a corre-
the sensorgram is denoted as the RU signal, whereas sponds to the amount of capture Mab1 (47P) remaining linked to the
matrix after the regeneration phase described above. Phase a to bthe time (in sec) is represented on the x axis. Figure 2
corresponds to the binding of 892 RU of TMVP. Phase b to c corre-shows two typical sensorgrams of two-site binding
sponds to the injection of Mab2 (16P). The negative response (0104
assays performed after direct immobilization of a capture RU) indicates that Mab 16P overlaps the epitope occupied by Mab
Mab1. 47P. Phase c to d corresponds to the regeneration phase. A flow rate
During two-site binding assays, continuous dissocia- of 5 ml/min was used during phases a to d.
tion and reassociation of one or more of the binding
partners occurs. When the kd of Mab1 is about 10
03
sec01, approximately half of the trapped antigen will be- to a positive RU response (Fig. 2A), the molar ratio (MR)
of Mab2/TMVP was calculated from MR  (D RU Mab2/come dissociated during the 10 min of Mab2 injection.
On the dissociated antigen molecule, the part of the sur- D RU TMVP)1 (MW TMVP/MW Mab) (Daiss and Scalice,
1994).face previously occupied by Mab1 may then bind to
Mab2 and this will prevent reassociation of the antigen MR values range from 0, for an interfering interaction
in which Mab1 and Mab2 fully overlap, to 1.0, for a nonin-to Mab1. This results in a lower RU response. In view of
the dynamic competition between different Mabs that terfering interaction in which Mab2 and Mab1 recognize
totally nonoverlapping epitopes. When injection of Mab2can be observed with the BIAcore, the type of epitope
mapping used in this study has been termed kinetic map- led to a negative RU response (Fig. 2B), the interaction
was considered as interfering.ping. The reversible nature of antigen–antibody interac-
tions can be visualized if the kd of the immobilized first Binding affinity and kinetics of antimetatope Mabs of
type E reacting with TMVP. Since TMVP tends to aggre-antibody lies in the region 1002 to 1004. If the kd value of
Mab1 is larger than 1002 sec01, no meaningful data can gate at the concentration needed to achieve sufficient
immobilization levels, it was not possible to immobilizebe obtained since practically all antigen molecules will
dissociate during the time frame of the experiment. directly monomeric viral protein on the sensor surface
(Saunal and Van Regenmortel, 1995). TMVP was there-Stoichiometry calculations. When injection of Mab2 led
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fore trapped by a covalently immobilized first Mab. Mab Mabs (Table 1). In contrast, the inhibitory efficiency of
antimetatope and antineotope Mabs of type E was very17V was used as capture Mab because it recognizes
surface A and was unlikely to influence the binding kinet- variable, some being able to inhibit disassembly at a
molar ratio of 50 or 100 Mabs/virion and others beingics of Mabs of type E added as second antibody. More-
over the reactivity of Mab 17V was shown not to decrease totally devoid of any activity (Table 1).
after several HCl regeneration cycles. TMVP was trapped
Kinetics measurementson the Mab 17V by injecting 30 ml of viral protein (0.26
mg/ml). Since no TMVP molecules were found to dissoci-
The binding affinity and kinetics of seven antimetatope
ate from the capture Mab 17V under mass transport con-
Mabs of type E were measured in order to establish
ditions (Karlsson et al., 1994), the observed kinetics of
if there was a correlation between the affinity and the
Mab2 are unlikely to be influenced by the fact that TMVP
inhibitory capacities of the antibodies. These particular
was immobilized via a first Mab.
Mabs were analyzed because they exhibited the greatest
After injection of TMVP, a flow of HBS buffer was main-
variability in inhibition capacity. In view of the low binding
tained for 500 sec to remove free TMVP. Mabs at concen-
stoichiometry of these Mabs to TMV particles, the kinet-
trations ranging from 5 to 35 nM in HBS were then al-
ics of binding were measured using the viral protein as
lowed to interact with the trapped TMVP. Runs were per-
antigen. As shown in Table 1, the ka values of the differentformed at 257, at a flow rate of 5 ml/min, taking report
Mabs ranged from 1 1 105 to 5 1 105 M01 sec01 and the
points (for dRU/dt and R values) every 0.5 sec. After the
kd values ranged from 3 1 1004 to 10 1 1004 sec01.association phase which lasted 10 min, HBS buffer was
Deviations from the mean for apparent rate constants
injected during the dissociation phase which extended
calculated in independent experiments were below 20%.
over 3 min. The BIAevaluation software 2.0 was used
The KA values ranged from about 1 1 108 to 11 1 108to process dRU/dt and RU values that were measured
M01. The small variations between the affinity of Mabs
automatically during the association and dissociation
were not correlated with their inhibitory capacity. For
phases. The processing of these data consists in correct-
instance, Mabs 16P and 25P which exhibited totally dif-
ing the possible background and in plotting values ac-
ferent inhibitory capacities were found to have the same
cording to different equations describing the mass action
apparent rate constants, whereas Mabs 25P and 151P
law. Our data were interpreted according to a nonlinear
which were both strong inhibitors exhibited a sixfold dif-
regression method (O’Shannessy et al., 1993; Malmqvist,
ference of affinity.
1993). According to this method dissociation rate con-
stant (kd) and association rate constant (ka) values are Two-site binding assays with TMVP
obtained from the dissociation and association phase,
respectively, for each binding experiment. Statistical cal- Since antineotope Mabs are unable to trap monomeric
TMVP, only antimetatope Mabs were used in two-siteculations carried out with the BIAevaluation software 2.0
indicated that the simplest interaction model A / B B binding assays with TMVP. Similar patterns of reactivity
were obtained with antimetatope Mabs 79P, 236P,AB was suitable and plots were shown to fit this model.
Each apparent rate constant corresponds to the mean 17V, 19V, 5V, and 6V recognizing surface A and results
will only be presented for two of these Mabs, i.e., 5Vof values calculated from 10 runs of interactions (two
independent experiments for five different Mab concen- and 17V.
A necessary control in this type of experiment consiststrations).
in using the same antibody as both 1st and 2nd antibody
in order to check that no oligomers are trapped by theRESULTS
Mab1. For the 11 Mabs listed in Table 2, this control
Inhibition of TMV RNA translation by Mabs
gave a zero response with 2 Mabs (25P and 29V) and a
negative RU response with the 9 other Mabs. A negativeThe inhibitory capacity of all Mabs whose epitope loca-
tion had been established with BIAcore (Saunal and Van response indicates that TMVP actually dissociated from
the capture Mabs. This phenomenon illustrates the re-Regenmortel, 1995) was measured at different molar ra-
tios of Mabs per virus particle, using slightly different versible nature of the antigen–antibody interaction. After
dissociating from the immobilized antibody, the TMVPconditions from the ones used previously (Saunal et al.,
1993). Mabs 249P and 236P were found to possess less molecules are able to bind to the same free antibody
introduced in the flow cell as Mab2 and this preventsinhibitory capacity than reported previously, whereas the
results with all other Mabs were the same. Three addi- TMVP–Mab2 complexes from reassociating to the immo-
bilized antibody.tional Mabs that had not been analyzed previously were
included in the present study (167P, 188P and 175P). In many of the tests in which different antibodies were
used as Mab1 and Mab2, zero or negative RU valuesAll antimetatope and antineotope Mabs of type A (Fig.
1) were found to inhibit virus disassembly at high molar were also obtained. When this result was observed inde-
pendently of the binding order tested, it was assumedratio of 200 Mabs/virion and only small differences in
inhibitory capacity were observed between the different that the two Mabs recognized overlapping epitopes.
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TABLE 1
Kinetic Binding Constants and Capacity of Mabs to TMV or TMVP to Inhibit Cotranslational Disassembly
Inhibitory capacity
(Molar ratio Mabs/virion) Kinetic constants
Mabs 200 100 50 ka (105) kd (1004) KA (108)
Antimetatope
type E 25P NDb /// /// 1.7 { 0.2 9.5 { 0.2 1.8 { 0.8
151P ND /// /// 4.9 { 0.4 4.8 { 0.2 10.2 { 1.2
181P ND /// /// 1.1 { 0.1 7.3 { 0.2 1.5 { 0.6
167P /// /// / 1.4 { 0.2 3.4 { 0.3 4.1 { 1.0
188P /// /// / 1.6 { 0.3 7.2 { 0.2 2.2 { 1.0
16P 0 0 0 1.7 { 0.2 9.9 { 0.2 1.7 { 0.8
47P 0 0 0 1.9 { 0.1 4.3 { 0.2 4.4 { 0.6
Antimetatope
type A 29V /// // /
79P /// // /
236P /// // /
17V // / /
19V // // /
5V / / 0
6V / / 0
175Pa / 0 0
Antineotope
type E 4P ND /// ///
67P ND /// ///
42P 0 0 0
Antineotope
type A 18V /// // /
249P /// / /
107P /// / /
7V // / /
253P / / /
Note. The inhibitory capacity of Mabs was assessed by examining radiolabeled TMV RNA translation products analyzed by electrophoresis and
autoradiography as described by Saunal et al., 1993.///, strong inhibition (the band corresponding to the 126-kDa viral protein was not detectable);
//, noticeable inhibition (the 126-kDa band was barely detectable); /, slight inhibition (the intensity of the 126-kDa band was slightly weaker than
the one obtained without Mab); 0, no effect (the intensity of the 126-kDa band was similar to that obtained in the control test).
a Mab 175P is specific for surface A of TMVP although it was found to bind to the extremity of TMV particles, presumably to the last row of
subunits.
b ND, not determined.
Pairs of Mabs that bound to overlapping sites are listed drawing representing surfaces A and E of TMVP is pre-
sented in Fig. 3A. The results presented in Table 3 com-in Table 3. In most of these cases the binding of Mab2
to a TMVP molecule that had dissociated from Mab1 bined with previously obtained information regarding
which surface, A or E, was recognized by each Mabprevented the reassociation of the antigen to Mab1 and
this contributed to a negative RU value. When the capture (Saunal and Van Regenmortel, 1995) were used to estab-
lish the relative position of the epitopes on the map (Fig.Mab was immobilized by means of a first layer of rabbit
anti-mouse globulins (Mabs 25P, 167P, 181P, and 188P), 3B). The combining sites of the antibodies were assumed
to cover a minimum surface of 600 A˚2 (Braden and Poljak,negative values may also partly be due to dissociation
of the capture Mab from RAM. This was certainly the 1995) in a circular footprint. We also assumed that two
Mabs are able to bind simultaneously to a TMVP mole-case, for instance, with Mab 25P, since the injection of
Mab 167P as second antibody led to value of 0186 RU, cule even if the corresponding epitopes have a common
border. A minimal distance separating two epitopes waswhereas the amount of bound TMVP was only 129 RU.
When combinations of Mabs led to a MR value (Mab2/ thus not considered necessary to permit simultaneous
binding of two Mabs.TMVP) higher than 0.1, it was assumed that the two Mabs
bound to nonoverlapping sites even if the reaction in the On the schematic epitope map presented in Fig. 3B,
three clusters of nonoverlapping epitopes can be distin-reverse order was not possible. MR values lower than
0.1 were considered to be equivocal. Pairs of Mabs that guished. The first one corresponds to epitopes recog-
nized by Mabs of type A (5V, 17V, 175P). The secondbound unequivocally to either overlapping or nonoverlap-
ping sites are listed in Table 3. A three-dimensional one, which adjoins face A, corresponds to epitopes on
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TABLE 3
Epitope Mapping Using Unambiguous Pairwise Interaction Data
Mabs TMVP surface Overlapping Mabs Nonoverlapping Mabs
25P (0.15), 151P (0.15), 175P (0.2–0.4), 5V (0.3–0.4), 17V
16P E 47P, 167P, 188P, 29V. (0.3–0.4).
16P (0.15), 47P (0.2), 175P (0.4–0.5), 5V (0.4–0.5), 17V
25P E (0.4–0.5), 29V (0.4–0.3).
25P (0.2), 151P (0.2), 167P (0.18), 175P (0.2–0.3), 181P
47P E 16P, 29V. (0.1), 188P (0.2), 5V (0.24–0.3), 17V (0.25–0.3).
16P (0.15), 47P (0.2), 175P (0.5–0.5), 5V (0.5–0.6), 17V
151P E 167P, 181P, 188P. (0.5–0.6), 29V (0.4–0.3).
167P E 16P, 151P, 181P, 188P. 47P (0.18), 175P (0.5–0.3), 29V (0.4–0.4).
47P (0.1), 175P (0.4–0.4), 5V (0.3–0.5), 17V (0.4–0.4), 29V
181P E 151P, 167P, 188P. (0.4–0.3).
188P E 16P, 151P, 167P, 181P. 47P (0.2), 175P (0.5–0.3), 29V (0.4–0.4).
16P (0.4–0.3), 25P (0.5–0.4), 47P (0.3–0.25), 151P (0.6–
5V A 175P, 17V, 29V. 0.5), 181P (0.5–0.3).
16P (0.4–0.3), 25P (0.5–0.4), 47P (0.25–0.3), 151P (0.5–
17V A 175P, 5V, 29V. 0.6), 181P (0.4–0.4).
25P (0.3–0.4), 151P (0.3–0.4), 167P (0.4–0.4), 181P (0.3–
29V A 16P, 47P, 175P, 5V, 17V. 0.4), 188P (0.4–0.4).
16P (0.4–0.2), 25P (0.5–0.4), 47P (0.3–0.2), 151P (0.5–0.5),
175P A 5V, 17V, 29V. 167P (0.3–0.5), 181P (0.4–0.4), 188P (0.3–0.5).
Note. Values in parentheses indicate stoichiometry of binding [MR values corresponding to (RU Mab2/RU TMVP) 1 (MW TMVP/MW Mab)].
surface E recognized by Mabs 16P and 47P. The third did not bind concurrently with some of the Mabs specific
one corresponds to epitopes recognized by Mabs 151P, for surface E (16P or 47P).
167P, 181P, and 188P. Mab 29V was found to overlap Mab 25P presents a special problem since when used
two of the antibody clusters recognizing surfaces A and as Mab2 in combination with Mabs 151P, 167P, 181P, or
E. Mab 29V was the only Mab specific for surface A that 188P, it produced an equivocal MR value of 0.06–0.07.
As surface E is unlikely to be able to accommodate more
than two Mabs and as Mab 25P bound clearly to a differ-
ent epitope from those recognized by Mabs 16P and 47P,
it was considered to overlap with Mabs 151P, 167P, 181P,
and 188P. This location is also consistent with the nega-
tive RU values observed with three of these antibodies
when Mab 25P was used as Mab1 (Table 2).
An examination of the epitope map (Fig. 3B) reveals
that Mabs devoid of inhibitory capacity (Mabs 16P, 47P)
bound to the part of surface E that adjoins surface A
while the inhibitory Mabs bound to the part of surface E
closest to the central axis of polymerized TMVP.
From the epitope map constructed on the basis of
pairwise interaction data, it seems that three molecules
of Mabs should be able to be accommodated simultane-
ously on surfaces A and E of each subunit. This was
verified by conducting multiple site binding assays taking
note of the proposed positions of nonoverlapping Mabs.
The results of these assays showed that several combi-
nations made it possible to accommodate three Mabs
on the combined surfaces A and E of a subunit. ForFIG. 3. (A) Schematic model of surfaces A and E of TMVP. Dimen-
instance, TMVP trapped by Mab 47P was able to accom-sions were calculated from data described by Namba and Stubbs
(1986) (the virus particle is 300 nm long, 18 nm in diameter with a modate both Mab 17V and Mab 151P (results not shown).
central hole of 0.4 nm, and possesses 2130 identical protein subunits Nonreciprocal results were obtained only when two
that form a helix of pitch 2.3 nm with 16 13 subunits in every turn). (B) Mabs of type E were tested for concurrent binding onSchematic epitope map constructed from pairwise interaction data (see
TMVP. In all these cases of nonreciprocity, a positiveTable 3). Each antibody-combining site was assumed to cover about
600 A˚2 in a circular footprint. result was obtained when Mab1 was a noninhibitory Mab
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and Mab2 was an inhibitory one. For instance, the combi- the locations of the corresponding epitopes. In two-site
binding assays, a monomeric antigen trapped by a firstnation Mab 47P/TMVP/25P was found to be possible,
whereas a negative result was obtained when the anti- antibody is tested for its ability to accommodate a second
antibody. The localization of epitopes in this type ofbodies were tested in the reverse order.
MR values corresponding to combinations that in- blocking assay is based on the assumption that a Mab
binding to a specific site hinders the attachment of an-volved pairs of Mabs able to bind concurrently to surface
E were low (0.15–0.2). Combinations involving Mabs that other antibody to the same or an overlapping site. The
resolution is of the order of the footprint of the antibody. Inbound to the part of surface E closest to surface A (47P)
with Mabs specific for face A (17V, 5V) were found to comparison with ELISA, the BIAcore technology provides
several advantages for epitope mapping (Daiss and Scal-give MR values of about 0.25–0.3. Higher MR values
(0.5–0.6) were obtained when Mabs that bound to the ice, 1994; Van Regenmortel et al., 1994; Saunal and Van
Regenmortel, 1995). The stoichiometry of binding of thepart of the surface E closest to the central axis of poly-
merized TMVP (25P, 151P, and 181P) were combined second antibody to the viral antigen can be expressed
in terms of molar ratio of bound Mab2/TMVP. Since thewith Mabs specific for surface A (17V, 5V). MR values
are thus clearly correlated with the distance between amount of TMVP trapped by different Mabs varied signifi-
cantly, the stoichiometry of binding rather than the abso-epitopes.
lute RU response corresponding to bound Mab2 was
used to infer epitope location. When the MR value wasDISCUSSION
higher than 0.1, it was assumed that the two Mabs bound
to nonoverlapping epitopes.The aim of this study was to explain why some Mabs
to TMVP had the capacity to block the in vitro uncoating When the same antibody was used as first and second
antibody a lowered RU response corresponding to theof the virus and others had not. One possibility was that
the binding affinity or kinetics of the Mabs was correlated amount of dissociated TMVP that was removed from the
matrix during Mab2 injection was obtained. When differ-with their inhibitory capacity but biosensor measure-
ments showed that this was not the case. Epitope map- ent Mabs2 were tested in conjunction with the same
Mab1, various levels of negative RUs were obtained. Forping by means of BIAcore was then undertaken to estab-
lish if there was a link between the location of epitopes instance, the combination 16P/TMVP/167P led to a RU
response of 0528 while a response of 0184 was ob-on the viral subunit and the inhibitory capacity of the
corresponding Mabs. tained with the combination 16P/TMVP/16P (Table 2).
This difference may be due to differences in the kd valuesIn a previous study, anti-TMVP Mabs whose specificity
had been determined by ELISA (Al Moudallal et al., 1985) of Mab 16P (1003 sec01) and Mab 167P (3 1 1004 sec01).
Since Mab 167P dissociated more slowly from TMVPwere tested for their ability to inhibit TMV RNA translation
(Saunal et al., 1993). Many antimetatope Mabs were than Mab 16P, it was more effective in preventing the
reassociation of dissociated TMVP to the immobilizedfound to possess inhibitory activity.
In a subsequent study (Saunal and Van Regenmortel, antibody.
Pairwise interaction data give information only on the1995), the location of the epitopes recognized by 14 anti-
TMVP Mabs and 7 anti-TMV Mabs was further investi- relative positions of epitopes since it is difficult to deter-
mine the orientation and the distances separating twogated using biosensor technology. Several of these
Mabs were found to have a specificity (neotope or meta- nonoverlapping epitopes. As a result epitope maps are
usually interpreted as functional ‘‘surface-like’’ mapstope) different from the one that was suggested by ELISA
results. Not all anti-TMVP Mabs whose inhibition capac- (Daiss and Scalice, 1994; Johne et al., 1993; Nice et al.,
1993; Tosser et al., 1994). In our system, several factorsity had previously been measured (Saunal et al., 1993)
were analyzed in BIAcore because insufficient quantities made it possible to construct a schematic map depicting
the actual physical location of the epitopes on the anti-were secreted by the hybridomas. Which surface of the
TMVP molecule is recognized by each Mab is indicated gen surface. Use was made of the known specificity for
surface A or E of each Mab. The small size of the proteinin Fig. 1.
The inhibitory capacity of the various anti-TMVP and together with the observation that one Mab specific for
surface A (29V) interfered with two Mabs specific foranti-TMV Mabs was more precisely measured at different
molar ratios of Mabs/virion (Table 1). The results showed surface E (16P and 47P) allowed the unambiguous posi-
tioning of Mabs on the TMVP surface.that half of the tested antimetatope and antineotope type
E Mabs strongly inhibited disassembly at a molar ratio Mab 175P recognized a particular type of epitope that
seemed to be located on surface E since the maximumof 50 or 100 Mabs/virion while the other half inhibited
weakly or not at all. In contrast all antimetatope and molar ratio of bound Mab 175P/TMV was about 10. Re-
sults of two-site binding assays indicated that Mab 175Pantineotope type A Mabs possessed a low inhibitory ca-
pacity. overlapped all Mabs reacting with surface A but failed
to interfere with any of the Mabs reacting with surfaceTwo-site binding assays were performed with 7 anti-
TMV Mabs and 16 anti-TMVP Mabs in order to determine E (Table 3). These results suggest that Mab 175P binds
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to an epitope located on surface A that is accessible only The binding of two nonoverlapping Mabs on TMVP led
to MR values ranging from 0.1 to 0.6. These MR valueson the last row of subunits in the polymerized particle,
presumably because of steric hindrance arising from the were correlated with the degree of proximity of epitopes
since Mabs that bound to adjacent epitopes led to thenext row of subunits along the length of the particle.
The epitope map showed that overlapping conforma- lowest MR values. In contrast, the low MR values ob-
served by Daiss and Scalice (1994) were not dependenttional antigenic sites formed a continuum on the surface
of the TMVP molecule. Mabs that were unable to block on the close proximity of the epitopes and these authors
suggested that the binding of a second antibody is anvirus disassembly were found to bind to the part of sur-
face E that adjoins surface A. In contrast, inhibitory Mabs all or none phenomenon. They suggested that low stoi-
chiometry of binding could arise from bivalent bindingwere found to bind to the region of surface E closest to
the central axis of polymerized TMVP which is known to of Mabs to two antigen molecules or from incomplete
saturation of the antigen because of too low affinity orinteract with the viral RNA. Since the complete 5* leader
of TMV RNA was shown to be uncoated before the initia- too low concentration of Mabs. In some cases, neither
an increase in concentration or volume injected nor thetion of cotranslational virus disassembly by ribosomes
(Mundry et al., 1991), it seems that inhibitory Mabs act use of Fab fragments changed the result, and other fac-
tors such as steric hindrance within the matrix were thenby preventing ribosomes from translocating on the viral
RNA and dislodging the viral subunits. Our mapping re- invoked. In our study, we used purified Mabs at high
concentration (150 mg/ml) and all antimetatope Mabs hadsults demonstrate the specificity of the recognition in-
volved in this type of viral neutralization since epitopes similar, high affinity constants (Table 1). In addition we
chose a long time of injection in order to achieve maxi-corresponding to inhibitory and noninhibitory Mabs of
type E were located very close to each other. Since inhibi- mum saturation of the epitopes. The correlation we ob-
served between low MR values and proximity of epitopestory Mabs probably prevent the ribosomes from inter-
acting with the virus, this mode of action resembles the may be explained by the steric hindrance that is likely
to occur when two Mabs bind to epitopes located veryneutralization mechanism operating when antibodies to
animal viruses prevent viruses from interacting with cel- close to each other. TMVP may be trapped by an antibody
according to various angles of attachment and only par-lular receptors (Dimmock, 1993).
Mabs that bound to the entire length of the viral particle ticular angles may allow the Mab2 to bind concurrently to
the same TMVP molecule. It is likely that this correlation(surface A) were all found to possess a low inhibitory
capacity. It is likely that these Mabs inhibited disassem- between low MR values and proximity of epitopes was
not found by Daiss and Scalice (1994) because the Mabsbly by a mechanism different from the one that operates
when Mabs react with the extremity of the virus rod (sur- they used did not recognize epitopes located close to-
gether on the same surface of the antigen molecule.face E). Mabs specific for surface A may prevent disas-
sembly of TMV by bridging viral subunits as in the case
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